A detailed history of Pfg Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pfg Investments, LLC holds 73,075 shares of BMY stock, worth $2.9 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
73,075
Previous 16,143 352.67%
Holding current value
$2.9 Million
Previous $828 Million 378.44%
% of portfolio
0.24%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $2.73 Million - $3.1 Million
56,932 Added 352.67%
73,075 $3.96 Billion
Q4 2023

Jan 17, 2024

BUY
$48.48 - $57.85 $127,890 - $152,608
2,638 Added 19.53%
16,143 $828 Million
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $79,946 - $89,392
-1,381 Reduced 9.28%
13,505 $784 Million
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $155,070 - $172,181
2,434 Added 19.55%
14,886 $952 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $818,220 - $928,047
12,452 New
12,452 $863 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.